{"prompt": "['Alliance A191402CD', '58.', 'Wong CA, Jim MA, King J, et al. Impact of hysterectomy and bilateral oophorectomy prevalence on', 'rates of cervical, uterine, and ovarian cancer among American Indian and Alaska Native women,', '1999-2004. Cancer Causes Control. Dec 2011;22(12): 1681-1689.', '59.', 'Jim MA, Perdue DG, Richardson LC, et al. Primary liver cancer incidence among American Indians', 'and Alaska Natives, US, 1999-2004. Cancer. Sep 1 2008;113(5 Suppl): 1244-1255.', '60.', \"D'Amico AV, Chen MH. Pretreatment prostate-specific antigen velocity and the risk of death from\", 'prostate cancer in the individual with low-risk prostate cancer. J Clin Oncol. Aug 1 2009;27(22):3575-', '3576.', '61.', \"D'Amico AV, Chen MH, Catalona WJ, Sun L, Roehl KA, Moul JW. Prostate cancer-specific mortality\", 'after radical prostatectomy or external beam radiation therapy in men with 1 or more high-risk factors.', 'Cancer. Jul 1 2007;110(1):56-61.', '62.', \"D'Amico AV, Cote K, Loffredo M, Renshaw AA, Schultz D. Determinants of prostate cancer-specific\", 'survival after radiation therapy for patients with clinically localized prostate cancer. J Clin Oncol. Dec', '1 2002;20(23):4567-4573.', '63.', \"D'Amico AV, Moul J, Carroll PR, Sun L, Lubeck D, Chen MH. Cancer-specific mortality after\", 'surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-', 'specific antigen era. J Clin Oncol. Jun 1 2003;21(11) :2163-2172.', '64.', \"D'Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy\", 'or external beam radiation therapy for patients with clinically localized prostate carcinoma in the', 'prostate specific antigen era. Cancer. Jul 15 2002;95(2):281-286.', '65.', \"D'Amico AV, Whittington R, Malkowicz SB, et al. Pretreatment nomogram for prostate-specific\", 'antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically', 'localized prostate cancer. J Clin Oncol. Jan 999;17(1):168-172.', '66.', 'Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded', 'prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life', 'in men with prostate cancer. Urology. Dec 20 2000;56(6):899-905.', '67.', 'Social Security Administration: Life Tables. http://www.ssa.gov/oact/STATS/table4c6.html', 'Accessed March 1, 2012.', '68.', \"Elwyn G, O'Connor A, Stacey D, et al. Developing a quality criteria framework for patient decision\", 'aids: online international Delphi consensus process. BMJ. Aug 26 5 2006;333(7565):417.', '69.', 'Knowing your options: A decision aid for men with localized prostate cancer.', 'ttp://www.effectivehealthcare.ahrq.gov/ehc/decisionaids/prostate-cancer/. Accessed January 1, 2012.', '70.', 'Stacey D, Bennett CL, Barry MJ, et al. Decision aids for people facing health treatment or screening', 'decisions. Cochrane Database Syst Rev. (10):CD001431', '71.', 'Donner A, Klar N. Design and analysis of cluster randomization trials in health research. London /', 'New York, N.Y.: Arnold; Co-published by the Oxford University Press; 2000.', '72.', 'Rosenberger WF, Lachin JM. Randomization in clinical trials : theory and practice. New York:', 'Wiley; 2002.', '73.', 'Beydoun HA, Mohan R, Beydoun MA, Davis J, Lance R, Schellhammer P. Development of a scale to', 'assess patient misperceptions about treatment choices for localized prostate cancer. BJU Int', '2010;106:334-41. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2888927/', '74.', \"O'Connor A. Validation of a decisional conflict scale. Med Decis Making 1995;15:25-3\", 'http://www.ncbi.nlm.nih.gov/pubmed/7898294', '75.', 'Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded', 'prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life', 'in men with prostate cancer. Urology 2000;56:899-905.', 'http://www.ncbi.nlm.nih.gov/pubmed/11113727', '38', 'Version Date: 11/30/2018', 'Update #06']['Alliance A191402CD', '76.', 'Clark JA, Talcott JA. Symptom indexes to assess outcomes of treatment for early prostate cancer.', 'Med Care 2001;39:1118-30. http://www.ncbi.nlm.nih.gov/pubmed/11567174', '77.', 'Clark JA, Wray NP, Ashton CM. Living with treatment decisions: regrets and quality of life among', 'men treated for metastatic prostate cancer. J Clin Oncol 2001;19:72-80.', 'http://www.ncbi.nlm.nih.gov/pubmed/11134197', '39', 'Version Date: 11/30/2018', 'Update #06']\n\n###\n\n", "completion": "END"}